Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)
China · Delayed Price · Currency is CNY 11.35
-0.49 (-4.14%)
Aug 27, 2026, 3:04 PM CST
SHE:002727 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 16,889 | 17,336 | 18,000 | 17,380 | 17,432 | 14,587 |
Revenue Growth | -4.09% | -3.69% | 3.57% | -0.29% | 19.50% | 15.26% |
Gross Profit Gross Profit Growth | 5,419 | 5,507 | 5,573 | 5,582 | 5,946 | 5,267 |
Operating Income Operating Income Growth | 524.56 | 528.4 | 383.26 | 843.93 | 1,318 | 1,185 |
Net Income Net Income Growth | 270.63 | 263.43 | 114.14 | 549.44 | 1,010 | 921.58 |
Earnings Per Share EPS Growth | 0.47 | 0.46 | 0.19 | 0.92 | 1.70 | 1.56 |
EPS Growth | 240.11% | 137.21% | -79.07% | -45.75% | 9.05% | 12.91% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Retail Retail Growth | 12,954 | 13,373 | 12,628 | 13,578 | 12,351 |
Wholesale Wholesale Growth | 3,782 | 4,089 | 3,901 | 3,320 | 1,924 |
Unallocated Other Operating Income Unallocated Other Operating Income Growth | 599.91 | 538.72 | 503.73 | 307.42 | 312.21 |
Total Total Growth | 17,336 | 18,000 | 17,380 | 17,432 | 14,587 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 3,466 | 3,062 | 3,418 | 3,895 | 3,520 | 2,532 |
Total Debt Total Debt Growth | 2,407 | 2,656 | 3,039 | 2,998 | 3,094 | 2,908 |
Net Cash (Debt) Net Cash Growth | 1,060 | 406.14 | 378.39 | 896.84 | 425.94 | -375.58 |
Net Cash Growth | 246.68% | 7.34% | -57.81% | 110.56% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.86 | 0.70 | 0.64 | 1.50 | 0.72 | -0.63 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,978 | 1,633 | 1,721 | 2,115 | 2,497 | 1,792 |
Capital Expenditures CapEx Growth | -291.11 | -278.29 | -254.83 | -253.46 | -348.98 | -391.63 |
Free Cash Flow Free Cash Flow Growth | 1,686 | 1,355 | 1,466 | 1,862 | 2,148 | 1,400 |
Free Cash Flow Growth | 18.86% | -7.55% | -21.28% | -13.33% | 53.43% | 85.89% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 32.09% | 31.77% | 30.96% | 32.12% | 34.11% | 36.11% |
Operating Margin | 3.11% | 3.05% | 2.13% | 4.86% | 7.56% | 8.13% |
Pretax Margin | 2.55% | 2.35% | 1.15% | 4.04% | 7.08% | 7.52% |
Profit Margin | 1.60% | 1.52% | 0.63% | 3.16% | 5.79% | 6.32% |
FCF Margin | 9.99% | 7.82% | 8.14% | 10.71% | 12.32% | 9.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 0.400 | 0.300 | 0.400 | 0.400 | 0.300 |
Dividend Per Share Growth | 33.33% | 33.33% | -25.00% | 0% | 33.33% | 0% |
Dividend Yield | 3.41% | 3.17% | 2.42% | 1.85% | 1.38% | 0.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 24.96 | 28.03 | 66.80 | 25.12 | 18.60 | 24.91 |
Forward PE | 14.98 | 12.43 | 10.17 | 13.00 | 16.59 | 19.48 |
P/FCF Ratio | 4.03 | 5.45 | 5.20 | 7.41 | 8.74 | 16.40 |
PS Ratio | 0.40 | 0.43 | 0.42 | 0.79 | 1.08 | 1.57 |